Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer.

Weekly chemotherapy with cyclophosphamide 80 mg m-2 day-1 p.o. continuously, methotrexate 35 mg m-2 week-1 i.v., 5-fluorouracil 500 mg m-2 week-1 i.v., vincristine 1.4 mg m-2 i.v. every two weeks and prednisolone 20 mg m-2 day-1 p.o. continuously (CMFVP) was prospectively studied in 45 previously un...

Descripción completa

Detalles Bibliográficos
Autores principales: Cebon, J. S., Bishop, J. F., Harvey, V., Mason, B., Jeal, P. N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971315/
https://www.ncbi.nlm.nih.gov/pubmed/2297484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971315/
https://www.ncbi.nlm.nih.gov/pubmed/2297484

Ejemplares similares